Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer

Xiao-Jie Bian1, Gui-Ming Zhang, Cheng-Yuan Gu

  • 1Department of Urology, Fudan University Shanghai Cancer Center, No. 270, Dong'an Road, Shanghai, 200032, China.

Insights

Dicer and Argonaute2 (Ago2) are crucial for microRNA synthesis and RNA interference. Their elevated expression in prostate cancer (Pca) correlates with disease progression, suggesting they are potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Dicer and Argonaute2 (Ago2) are key enzymes in microRNA biogenesis and RNA interference pathways.
  • MicroRNAs play significant roles in regulating gene expression and are implicated in various cancers, including prostate cancer (Pca).

Purpose of the Study:

  • To investigate the expression levels and functional roles of Dicer and Ago2 in prostate cancer.
  • To evaluate the potential of Dicer and Ago2 as biomarkers for Pca progression and as therapeutic targets.

Main Methods:

  • Immunohistochemistry (IHC) was used to assess Dicer and Ago2 expression in Pca tissues and compare with pathological features.
  • RNA interference (RNAi) was employed to down-regulate Dicer and Ago2 in Pca cell lines (LNCaP, PC-3, DU145).
  • Cell proliferation, apoptosis, and cell cycle distribution were analyzed using CCK-8 assays and flow cytometry.

Main Results:

  • Dicer and Ago2 expression levels were significantly higher in Pca tissues compared to adjacent benign tissues.
  • Higher expression of Dicer and Ago2 correlated with lower Gleason patterns in Pca, indicating a role in disease progression.
  • Silencing Dicer or Ago2 inhibited proliferation, induced apoptosis, and caused cell cycle arrest (G2/M or S phase) in Pca cell lines.

Conclusions:

  • Dicer and Ago2 are critically involved in regulating proliferation, apoptosis, and cell cycle progression in prostate cancer.
  • These proteins represent promising biomarkers for monitoring Pca progression.
  • Dicer and Ago2 emerge as potential therapeutic targets for prostate cancer treatment.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K